Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt) has been approved by the US Food and Drug Administration (FDA) to treat ...

UCB’s Bimzelx (bimekizumab) has been approved by the European Commission (EC) to treat active moderate-to-severe hidradenitis ...

Xaira Therapeutics, a new biotech aiming to “re-engineer” drug discovery and development using artificial intelligence (AI), ...

Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming ...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration aimed at developing CRISPR-based gene ...

Johnson & Johnson’s (J&J) Rybrevant (amivantamab) in combination with chemotherapy, has been recommended by the European ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) in combination with its endocrine therapy Faslodex (fulvestrant) has ...

Takeda has announced that its subcutaneous (SC) Entyvio (vedolizumab) has been approved by the US Food and Drug ...

The use of systemic radioactive medications as cancer therapies dates back to the 1940s when radioactive iodine was employed ...

Afon Technology has been presented with Junkosha’s Technology Innovator of the Year Award, along with a $25,000 prize, for ...